| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.28 | 8e-06 |